MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+32.51%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$427M
AUM Growth
+$427M
(+14%)
Cap. Flow
-$7.07M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
60.67%
Holding
34
New
2
Increased
10
Reduced
13
Closed
2
Top Buys
| 1 |
ALX Oncology
ALXO
|
$18.8M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$3.57M |
| 3 |
Disc Medicine
IRON
|
$2.89M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$23.3K |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$21.8K |
Top Sells
| 1 |
Relay Therapeutics
RLAY
|
$5.73M |
| 2 |
KalVista Pharmaceuticals
KALV
|
$5.57M |
| 3 |
Travere Therapeutics
TVTX
|
$4.94M |
| 4 |
Intellia Therapeutics
NTLA
|
$4.94M |
| 5 |
Viridian Therapeutics
VRDN
|
$3.38M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cullinan Oncology
CGEM
$445M
| $77.9M | 18.23% | 7,648,268 | – | – |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $26.7M | 6.26% | 3,289,470 +2,073 | +0.1% | +$16.9K |
|
3
Olema Pharmaceuticals
OLMA
$375M
| $26.1M | 6.1% | 1,857,136 -545 | -0% | -$7.65K |
|
4
Geron
GERN
$893M
| $22.6M | 5.29% | 10,715,620 +3,139 | +0% | +$6.62K |
|
5
iTeos Therapeutics
ITOS
| $19.1M | 4.47% | 1,745,943 | – | – |
|
|
6
ALX Oncology
ALXO
$62.7M
| $18.8M | 4.41% | +1,264,759 | New | +$18.8M |
|
|
7
MoonLake Immunotherapeutics
MLTX
$3.54B
| $17.8M | 4.16% | 294,576 +386 | +0.1% | +$23.3K |
|
8
Crinetics Pharmaceuticals
CRNX
$2.92B
| $17M | 3.98% | 478,234 -819 | -0.2% | -$29.1K |
|
|
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $16.9M | 3.95% | 53,279 +69 | +0.1% | +$21.8K |
|
10
Insmed
INSM
$28.8B
| $16.4M | 3.83% | 528,150 +692 | +0.1% | +$21.4K |
|
|
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
| $14.4M | 3.38% | 611,181 +411 | +0.1% | +$9.71K |
|
12
Repare Therapeutics
RPTX
$71.7M
| $12M | 2.8% | 1,639,849 | – | – |
|
|
13
Intellia Therapeutics
NTLA
$1.22B
| $11.7M | 2.73% | 382,598 -162,041 | -30% | -$4.94M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $10.2M | 2.38% | 715,883 -256 | -0% | -$3.63K |
|
15
Regenxbio
RGNX
$451M
| $9.86M | 2.31% | 549,078 -107,640 | -16% | -$1.93M |
|
16
Madrigal Pharmaceuticals
MDGL
$9.76B
| $9.47M | 2.21% | 40,910 +51 | +0.1% | +$11.8K |
|
17
Structure Therapeutics
GPCR
$1.11B
| $9.4M | 2.2% | 230,696 -65 | -0% | -$2.65K |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $9.39M | 2.2% | 664,986 +762 | +0.1% | +$10.8K |
|
|
MORF
19
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.35M | 2.19% | 323,742 +123,742 | +62% | +$3.57M |
|
20
Werewolf Therapeutics
HOWL
$59.9M
| $9.22M | 2.16% | 2,388,011 | – | – |
|
|
21
Relay Therapeutics
RLAY
$619M
| $9.16M | 2.14% | 832,017 -520,116 | -38% | -$5.73M |
|
22
Xeris Biopharma Holdings
XERS
$1.26B
| $9.04M | 2.12% | 3,847,232 -140,735 | -4% | -$331K |
|
|
VERV
23
DELISTED
Verve Therapeutics
VERV
| $8.9M | 2.08% | 638,163 -219,777 | -26% | -$3.06M |
|
24
Revolution Medicines
RVMD
$7.1B
| $7.84M | 1.83% | 273,408 | – | – |
|
25
Axsome Therapeutics
AXSM
$6.05B
| $7.43M | 1.74% | 93,387 -199 | -0.2% | -$15.8K |
|